Abstract: Techniques and systems for neutralizing discharge waters from ballast and/or cooling water biocidal treatment and disinfection systems are provided. The systems utilize oxidation reduction potential control to regulate the dechlorination of a biocidal agent to allowable discharge levels in ship buoyancy systems and ship cooling water systems.

Abstract: Techniques and systems for neutralizing discharge waters from ballast and/or cooling water biocidal treatment and disinfection systems are provided. The systems utilize oxidation reduction potential control to regulate the dechlorination of a biocidal agent to allowable discharge levels in ship buoyancy systems and ship cooling water systems.

Abstract: Techniques and systems for neutralizing discharge waters from ballast and/or cooling water biocidal treatment and disinfection systems are provided. The systems utilize oxidation reduction potential control to regulate the dechlorination of a biocidal agent to allowable discharge levels in ship buoyancy systems and ship cooling water systems.

Abstract: Techniques and systems for neutralizing discharge waters from ballast and/or cooling water biocidal treatment and disinfection systems are provided. The systems utilize oxidation reduction potential control to regulate the dechlorination of a biocidal agent to allowable discharge levels in ship buoyancy systems and ship cooling water systems.

Abstract: A composition formulated for diversion- and/or abuse-resistance, includes at least one active pharmaceutical ingredient (API), each present in an acidic form, a first compound capable of coupling to the acidic form of the API to form a complex, where the resulting complex is resistant to separation by conventional separation methods, and a second compound capable of preferentially coupling to the first compound to thereby release the API from the complex.

Abstract: A composition formulated for diversion- and/or abuse-resistance, includes at least one active pharmaceutical ingredient (API), each present in an acidic form, a first compound capable of coupling to the acidic form of the API to form a complex, where the resulting complex is resistant to separation by conventional separation methods, and a second compound capable of preferentially coupling to the first compound to thereby release the API from the complex.

Abstract: A composition formulated for diversion- and/or abuse-resistance, includes at least one active pharmaceutical ingredient (API), each present in an acidic form, a first compound capable of coupling to the acidic form of the API to form a complex, where the resulting complex is resistant to separation by conventional separation methods, and a second compound capable of preferentially coupling to the first compound to thereby release the API from the complex.

Abstract: Ballast and/or cooling water biocidal treatment and disinfection systems and techniques are provided. The systems utilize oxidation reduction potential control to regulate addition, or concentration of an electrocatalytically generated biocidal agent to disinfection levels in ship buoyancy and to biofouling levels in ship cooling water systems. The disinfection and biofouling control systems provide suitable treatment while reducing the potential for corrosion of ship components and, in some cases, undesirable disinfection byproducts.

Abstract: A chlorine based biofouling control subsystem is utilized to facilitate shipboard water management systems such as ballast water management that employ filters. The biofouling control system can serve as a subsystem to promote antifouling and reduce the filter clogging due to biofouling, which improves the efficiency and effectiveness of the ballast water treatment management system. An antifouling agent of the biofouling control system breaks up the dense colonies of marine organisms being filtered or treated by the main water management systems.

Abstract: A composition formulated for diversion- and/or abuse-resistance, includes at least one active pharmaceutical ingredient (API), each present in an acidic form, a first compound capable of coupling to the acidic form of the API to form a complex, where the resulting complex is resistant to separation by conventional separation methods, and a second compound capable of preferentially coupling to the first compound to thereby release the API from the complex.

Abstract: A chlorine based bio-fouling control subsystem is utilized to facilitate shipboard water management systems such as ballast water management that employ filters. The biofouling control system can serve as a subsystem to promote antifouling and reduce the filter clogging due to biofouling, which improves the efficiency and effectiveness of the ballast water treatment management system. An antifouling agent of the biofouling control system breaks up the dense colonies of marine organisms being filtered or treated by the main water management systems.

Abstract: Ballast and/or cooling water biocidal treatment and disinfection systems and techniques are provided. The systems utilize oxidation reduction potential control to regulate addition, or concentration of an electrocatalytically generated biocidal agent to disinfection levels in ship buoyancy and to biofouling levels in ship cooling water systems. The disinfection and biofouling control systems provide suitable treatment while reducing the potential for corrosion of ship components and, in some cases, undesirable disinfection byproducts.

Abstract: Electrocatalytic generation of halogenated biocides are disclosed by electrolyzing low salinity water with an applied current. The direction of the applied current is reversed periodically, for a shorter duration, and at a lower current density. Mixed types of electrodes are utilized without a significant reduction in reliability and performance.

Abstract: The invention provides low cost methods and apparatus that utilize at least one carbon-filled polymeric electrode to electrolytically generate desirable products.

Abstract: Active bromine-containing solutions are produced and stabilized by reacting bromate and bromide salt solutions with an amino-complexing agent, such as sulfamic acid or sulfamate salt. The reaction is performed at a pH of less than 1 to create a complexed hypobromate. The pH of the active bromine-containing solution is raised to between 4 and 10 by adding an alkali to improve stability. Moreover, the solution is maintained below 30° C. during the alkali addition to retain bromine equivalent activity.

Abstract: An electrolytic cell producing sodium chlorate uses an electrode, specifically an anode, having a surface or coating or treatment of a mixed metal oxide having ruthenium oxide as an electrocatalyst, a precious metal of the platinum group or its oxide as a stability enhancer, antimony oxide as an oxygen suppressant and a titanium oxide binder. The electrocatalytic coating is about 21 mole percent ruthenium oxide, about 2 mole percent iridium oxide, about 4 mole percent antimony oxide and the balance is titanium oxide. The coating is characterized by high durability and low oxygen content in an off-gas.

Abstract: A composition that includes Sea Buckthorn Oil may be used as a cosmetic product, a pharmaceutical or nutraceutical product or a food product. The composition maintains its distinctive color, due to the use of Sea Buckthorn Oil, over time, even when exposed to oxygen and/or U.V. light. The color of Sea Buckthorn Oil is maintained by adding to the composition Sea Buckthorn Oil in an amount from 0.01 to 90% by weight and an antioxidant and/or a U.V. filter in an amount from 0.001 to 20% by weight.

Abstract: Active bromine-containing solutions are produced and stabilized by reacting bromate and bromide salt solutions with an amino-complexing agent, such as sulfamic acid or sulfamate salt. The reaction is performed at a pH of less than 1 to create a complexed hypobromate. The pH of the active bromine-containing solution is raised to between 4 and 10 by adding an alkali to improve stability. Moreover, the solution is maintained below 30° C. during the alkali addition to retain bromine equivalent activity.

Abstract: An electrolytic cell producing sodium chlorate uses an electrode, specifically an anode, having a surface or coating or treatment of a mixed metal oxide having ruthenium oxide as an electrocatalyst, a precious metal of the platinum group or its oxide as a stability enhancer, antimony oxide as an oxygen suppressant and a titanium oxide binder. The electrocatalytic coating is about 21 mole percent ruthenium oxide, about 2 mole percent iridium oxide, about 4 mole percent antimony oxide and the balance is titanium oxide. The coating is characterized by high durability and low oxygen content in an off-gas.

Abstract: An electrode having an electrocatalytic surface or coating composed of a mixture with iridium oxide is used in a reversible polarity electrolytic cell to selectively produce an alkali metal hypohalite, preferably sodium hypochlorite, from brine made from hard water. The mixture also may have a platinum group metal oxide and a valve metal oxide, preferably, ruthenium oxide and titanium oxide respectively.